Quality Improvement Project of Nurse Guiding Incentive Spirometry After Cardiac Surgery

Interprofessional Collaborative Practice Between Respiratory Therapists and Nurses- Quality Improvement Project of the Correct Rate of Nurse Guiding Incentive Spirometry After Cardiac Surgery

Studies have shown that patients undergoing general anesthesia surgery are prone to pulmonary complications after surgery; about 30-72% of cardiac surgery patients have postoperative chest X-rays that reveal lung collapse, leading to gas exchange disorders and hypoxemia. Postoperative lung expansion therapy can increase ventilation-perfusion balance, increase lung volume, promote respiratory mucosal sputum production and reduce postoperative pain, and has been proven to improve postoperative pulmonary-related complications.

Inducement spirometry is currently one of the mainstream methods of performing lung expansion treatment. It uses visual feedback to allow the patient to perform slow, deep breathing with sufficient airflow or volume to achieve the lung expansion effect; it is also used after cardiac surgery in our hospital. The main way for patients to perform lung expansion therapy; compared with only performing respiratory exercises after surgery, induced spirometry can reduce the incidence of lung collapse and respiratory distress in postoperative patients, and can also shorten the ICU stay and total hospitalization stay.

Most cardiac surgery patients in our hospital are given health education on lung expansion therapy by nursing staff before and after surgery. This unit does not have specialized courses on lung expansion therapy, which may lead to differences in explanations between different nursing staff; some patients' lack of knowledge and understanding of lung expansion treatment resulted in the treatment effect not being as good as expected, which motivated the author to formulate a project for improvement. We hope to analyze, review and improve the current situation to improve the effectiveness of lung expansion treatment for patients.

Based on the current situation analysis and relevant literature, a project to improve nursing guidance for lung expansion therapy was implemented.

Study Overview

• Status: Not yet recruiting
• Conditions: Post-cardiac Surgery; Lung Expansion Therapy
• Intervention / Treatment: Behavioral: on-the-job training of lung expansion therapy

Detailed Description

The following options were selected as solutions:

1. Develop Inducement Spirometry Care Standards
2. Organize in-service education courses on pulmonary dilatation therapy for nursing staff
3. Make a health education leaflet on incentive spirometer and place it in the ward for patients to read.
4. Provide demonstration materials for nursing staff to experience the treatment process

The main purposes are:

1. Improve nursing staff's awareness of lung expansion therapy
2. Improve the accuracy of nursing staff in performing lung expansion therapy and health education
3. Improve the accuracy of patients' lung expansion therapy
4. Reduce the incidence of pulmonary complications in patients after cardiac surgery

• Study Type: Interventional
• Enrollment (Estimated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Yi-Ting Hung, Bachelor; Phone Number: +886-910720142; Email: birdymkii@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Nurses:

Inclusion Criteria:

• Nurse staff in cardiovascular surgery ICU of National Taiwan University Hospital

Exclusion Criteria:

• None

Patients:

Inclusion Criteria:

• 18 years of age and above
• Perform cardiovascular surgeries at National Taiwan University Hospital
• After surgery, the endotracheal tube is inserted and admitted to the cardiovascular surgery intensive care unit, and the endotracheal tube is removed in the intensive care unit.
• There is a clinical indication to perform lung expansion therapy
• Clear consciousness and able to cooperate with instructions

Exclusion Criteria:

• Hemodynamic instability (mean arterial pressure remains below 60 mmHg after infusion or vasopressor administration)
• Severe lung diseases (such as uncontrollable asthma, severe pulmonary obstruction, untreated pneumothorax, etc.)
• Unable to perform effective deep breathing (for example: vital capacity is less than 10 ml/kg or inspiratory capacity is less than 1/3 of the predicted value)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: the cardiovascular surgery ICU nurse staff; on-the-job training of lung expansion therapy	Behavioral: on-the-job training of lung expansion therapy; on-the-job training of lung expansion therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The improvement of nursing staff's awareness rate of lung expansion therapy	The improvement before and after on-the-job training	week 2 after on-the-job training
The improvement of nursing staff's correct rate of education of lung expansion therapy	The improvement before and after on-the-job training	week 2 after on-the-job training

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
The improvement of patients' correct rate of lung expansion therapy	The improvement before and after nurse staff's on-the-job training	week 2 after nurse staff's on-the-job training
The improvement of respiratory complication rate	The improvement before and after nurse staff's on-the-job training	week 2 after nurse staff's on-the-job training
Nurses' satisfaction of the quality improvement project survey	Nurses' satisfaction of the quality improvement project	week 2 after nurse staff's on-the-job training

Collaborators and Investigators

• Sponsor: National Taiwan University Hospital

Study record dates

Study Major Dates

• Study Start (Estimated): September 6, 2023
• Primary Completion (Estimated): December 31, 2023
• Study Completion (Estimated): January 31, 2024

Study Registration Dates

• First Submitted: September 11, 2023
• First Submitted That Met QC Criteria: September 15, 2023
• First Posted (Actual): September 18, 2023

Study Record Updates

• Last Update Posted (Actual): September 18, 2023
• Last Update Submitted That Met QC Criteria: September 15, 2023
• Last Verified: September 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: 202308062RINB

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No